330728P

C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0)

Avanti Research^™ - A Croda Brand

• 同義詞: D-galactosyl-β-1,1′-N-tridecanoyl-D-erythro-sphingosine-d7
• 經驗公式（希爾表示法）: C₃₇H₆₄D₇NO₈
• CAS號碼: 2315262-19-0
• 分子量：: 665.00
• 分類程式碼代碼: 12352211
• NACRES: NA.12

屬性

• 化驗: 99% (TLC)
• 形狀: powder
• 包裝: pkg of 1 × 1 mg (330728P-1MG)
• 製造商／商標名: Avanti Research^™ - A Croda Brand
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• SMILES 字串: [H][C@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@@]([H])(NC(CCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H](O)[C@H]1CO

描述

一般說明

C13 Galactosyl(β) Ceramide-d7 (d18:1-D7/13:0) is deuterated derivative of C13 Galactosyl(β) Ceramide. β-Galactosyl ceramide (β −GalCer) is one of the uncomplicated glycosphingolipid. It contains a lipophilic sphingosine and a hydrophilic galactose moiety, which is attached to sphingosine via an ether linkage. It is localized in the myelin sheath of the peripheral and central nervous system.

生化／生理作用

β-Galactosyl ceramide (β −GalCer) plays a role in regulating the activity of β-glucocerebrosidase (β-GlcCer′ase). It is also a receptor for various bacterial and viral toxins.

包裝

5 mL Amber Glass Screw Cap Vial

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 儲存類別代碼: 11 - Combustible Solids
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable